RxDoctor Payments Data

Raphael Bueno, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Boston, MANPI 1982695540

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (34.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Medtronic at 26.7% of the total. Reporting peaked in 2019 at $3,095 and has fallen 83.2% since, to $518 in 2025.

$10,134in general payments, 2019–2025

Across 38 payments — averaging $266.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Regeneron$2K
  • F. Hoffmann-la Roche AG$2K
  • Intuitive Surgical$1K
  • Siemens Medical Solutions USA, Inc.$1K
  • Baxter Healthcare$280
  • plus $160 from 1 others
$1,398,469in research payments, 2019–2025

Across 29 payments — averaging $48,223 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$649K
  • Merck$404K
  • Siemens Medical Solutions USA, Inc.$174K
  • Verastem, Inc.$111K
  • Intuitive Surgical Operations, Inc.$60K

What the payments were for

  • Consulting fees$3,51535%
  • Speaking & faculty fees$1,50015%
  • Travel & lodging$3,48134%
  • Food & beverage$1,63716%

General payments by program year

19
20
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,134 in reported general payments places this provider in the 65th percentile of 171 thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Massachusetts

Medicare billing

Part B allowed, 2024
$163,330
Medicare patients
455
Services billed
888

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →